OVIT (OncoVista Innovative Therapies) EBITDA Margin %: 0.00% (As of Sep. 2015)


What is OncoVista Innovative Therapies EBITDA Margin %?

OncoVista Innovative Therapies OVIT EBITDA Margin % is 0.00% as of Sep. 2015.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. OncoVista Innovative Therapies's EBITDA for the three months ended in Sep. 2015 was $-0.32 Mil. OncoVista Innovative Therapies's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, OncoVista Innovative Therapies's EBITDA margin for the quarter that ended in Sep. 2015 was 0.00%.

OncoVista Innovative Therapies  (OTCPK:OVIT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

OncoVista Innovative Therapies EBITDA Margin % Related Terms

OncoVista Innovative Therapies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies EBITDA Margin % Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OVIT vs RSPI, HSTC, CAPS: EBITDA Margin % Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's EBITDA Margin % falls into.


OncoVista Innovative Therapies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

OncoVista Innovative Therapies's EBITDA Margin % for the fiscal year that ended in Dec. 2014 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-2.545/0
= %

OncoVista Innovative Therapies's EBITDA Margin % for the quarter that ended in Sep. 2015 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2015 )/Revenue (Q: Sep. 2015 )
=-0.317/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
OncoVista Innovative Therapies (OVIT) has a EBITDA Margin % of 0.00% as of Sep. 2015. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' EBITDA Margin % too high?
OncoVista Innovative Therapies' current EBITDA Margin % is 0.00%.
How does OncoVista Innovative Therapies' EBITDA Margin % compare to RSPI and HSTC?
OncoVista Innovative Therapies' EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current EBITDA Margin % is 0.00% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.